United States District Court for the Northern District of Illinois Case No. 19-cv-08402
IF YOU SCANNED YOUR FINGER AT AN OCTAPHARMA PLASMA FACILITY IN ILLINOIS BETWEEN DECEMBER 2, 2014 AND FEBRUARY 4, 2020, YOU CAN CLAIM A PAYMENT FROM A CLASS ACTION SETTLEMENT.
This is an official court website. You are not being sued. This is not an ad for a lawyer.
A settlement has been reached in a class action lawsuit between Octapharma Plasma, Inc. (“Defendant” or “Octapharma”) and certain plasma donors who scanned their finger at an Octapharma plasma donation facility in the State of Illinois and listed an Illinois address. The lawsuit claims that Octapharma violated an Illinois law called the Illinois Biometric Information Privacy Act (“BIPA”) when it collected individuals’ biometric data through its donor identification system with a finger scanner without complying with the law’s requirements. Octapharma denies those allegations and the law’s applicability to Octapharma. The Court has not decided who is right or wrong. The Settlement has been preliminarily approved by a federal court in Chicago, Illinois.
You are included in the Settlement if you scanned your finger and provided an Illinois address at an Octapharma blood plasma donation facility in Illinois between December 2, 2014 and February 4, 2020. If you received a notice of the Settlement in the mail or by e-mail, our records indicate that you are a Settlement Class Member and are included in the Settlement, and you may submit a Claim Form online or by mail to receive a cash payment.
If the Court approves the Settlement, members of the Class who submit valid claims will receive an equal, or pro rata, share of a $9,987,380 settlement fund that Octapharma has agreed to establish, after all notice and administration costs, incentive award, and attorneys’ fees have been paid. Individual payments to Settlement Class Members who submit a valid Claim Form are estimated to be $400 to $800, but could be more or less depending on the number of valid claims submitted.
Please read this website carefully. Your legal rights are affected whether you act, or don’t act.
YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT
SUBMIT A CLAIM FORM
This is the only way to receive a payment. You must submit a complete and valid claim form either onlineor by mail before February 3, 2022.
You will receive no payment under the Settlement and give up your rights to sue Octapharma or certain related companies and individuals about the issues in this case.
You will receive no payment, but you will retain any rights you currently have to sue Octapharma about the issues in this case.
Write to the Court explaining why you don’t like the Settlement.
ATTEND A HEARING
Ask to speak in Court about the fairness of the Settlement.
These rights and options—and the deadlines to exercise them—are explained on the website.
The Court in charge of this case still has to decide whether to approve the Settlement. Payments will be provided only after any issues with the Settlement are resolved. Please be patient.
PLEASE DO NOT CONTACT THE COURT, THE JUDGE, THE DEFENDANT OR THE DEFENDANT’S LAWYERS WITH QUESTIONS ABOUT THE SETTLEMENT OR DISTRIBUTION OF SETTLEMENT PAYMENTS.
This website is authorized by the Court, supervised by counsel and controlled by the Settlement Administrator approved by the Court. This is the only authorized website for this case.
Thursday, January 27, 2022
You must submit your request for exclusion so that it is postmarked or received no later than Thursday, January 27, 2022.
Thursday, January 27, 2022
You must submit your objection and/or notice of intent to appear at the Final Approval Hearing so that it/they are postmarked or received no later than Thursday, January 27, 2022.
Claim Form Deadline
Thursday, February 3, 2022
You must submit your Claim Form so that it is postmarked or received no later than Thursday, February 3, 2022.
Final Approval Hearing Date
Wednesday, February 16, 2022
The Final Approval Hearing will be held on February 16, 2022 at 9:00 a.m. via telephone conference. Instructions to access the telephone conference are at FAQ #18. Please check this website for updates.